Skip to main content

Advertisement

Springer Nature is making Coronavirus research free. View research | View latest news | Sign up for updates

Table 2 Summary of published articles regarding rubella seroprevalence in general population in Africa between 2002 and 2014

From: Serological makers of rubella infection in Africa in the pre vaccination era: a systematic review

Location/Country Population Age
(years)
Sample size IgG+ Cut off points Study period References
Oyo state, Nigeria Reproductive age 15–45 230 215 (93.4 %) NR 2002 [53]
Vom, Nigeria   20–65 96 87 (90.6 %) NR NR [54]
Kenya Children 4–20 498 398 (79.9 %) NR Feb–June 2005 [12]
Uganda Adults 20–62 311 309 (99.3 %) NR NR [55]
Bangui, Central Republic of Africa Children 1 month–15 395 218 (55.1 %) ≥15 IU/ml July–Dec2008 [13]
Algeria Reproductive age 15–49 834 572 (68.6 %) >10 IU/ml March 2005–March 2007 [56]
Senegal Reproductive age 15–45 3471 3127 (90 %) >10 IU/ml March–June 2002 [57]
Egypt Women 6–45 Urban = 172
Rural = 426
Urban = 170 (98.8 %)
Rural = 386 (90.6 %)
Overall (96.3 %)
>15 IU/ml NR [58]
Lagos, Nigeria HIV population 18–60 80 59 (73.8 %) NR April 2011–May 2012 [59]
Morocco Reproductive age 15–39 Urban = 502
Rural = 465
Urban = 427 (85.1 %)
Rural = 379 (81.5 %)
Overall (83.3 %)
>8.6 IU/ml 2000 [60]
Total     84.8 % (55.1–99.3 %)    
  1. NR not reported